[{"notes_id":"1_1406","category":"11","subcategory":"1","title":"Implantable contraceptives","body":"Implanon was the original non-biodegradable <span class=\"concept\" data-cid=\"281\">subdermal<\/span> contraceptive implant which has been replaced by Nexplanon. From a pharmacological perspective Nexplanon is the same as Implanon. The two main differences are:<br \/><ul><li>the applicator has been redesigned to try and prevent 'deep' insertions (i.e. subcutaneous\/intramuscular)<\/li><li>it is radiopaque and therefore easier to locate if impalpable<\/li><\/ul><br \/>Both versions slowly releases the progestogen hormone etonogestrel. They are typically inserted in the proximal non-dominant arm, just overlying the tricep. The main mechanism of action is <span class=\"concept\" data-cid=\"282\">preventing ovulation<\/span>. They also work by thickening the cervical mucus.<br \/><br \/>Key points<br \/><ul><li>highly effective: failure rate 0.07\/100 women-years - <span class=\"concept\" data-cid=\"9659\">it is the most effective form of contraception<\/span><\/li><li>long-acting: lasts 3 years<\/li><li>doesn't contain oestrogen so can be used if past history of thromboembolism, migraine etc<\/li><li>can be inserted immediately following a termination of pregnancy<\/li><\/ul><br \/>Disadvantages include<br \/><ul><li>the need for a trained professional to insert and remove device<\/li><li>additional contraceptive methods are needed for the first <span class=\"concept\" data-cid=\"283\">7 days<\/span> if not inserted on day 1 to 5 of a woman's menstrual cycle<\/li><\/ul><br \/>Adverse effects<br \/><ul><li><span class=\"concept\" data-cid=\"4094\"><b>irregular\/heavy bleeding<\/b><\/span> is the main problem: this is sometimes managed using a <span class=\"concept\" data-cid=\"4090\">co-prescription of the combined oral contraceptive pill<\/span>. It should be remembered to do a <span class=\"concept\" data-cid=\"4093\">speculum exam\/STI<\/span> check if the bleeding continues<\/li><li>'progestogen effects': headache, nausea, breast pain<\/li><\/ul><br \/>Interactions<br \/><ul><li>enzyme-inducing drugs such as certain antiepileptic and rifampicin may reduce the efficacy of Nexplanon<\/li><li>the FSRH advises that women should be advised to switch to a method unaffected by enzyme-inducing drugs or to use additional contraception until 28 days after stopping the treatment<\/li><\/ul><br \/>Contraindications<br \/><ul><li>UKMEC 3*: <span class=\"concept\" data-cid=\"9033\">ischaemic heart disease<\/span>\/<span class=\"concept\" data-cid=\"9034\">stroke<\/span> (for continuation, if initiation then UKMEC 2), unexplained, suspicious vaginal bleeding, <span class=\"concept\" data-cid=\"9035\">past breast cancer<\/span>, <span class=\"concept\" data-cid=\"9036\">severe liver cirrhosis<\/span>, <span class=\"concept\" data-cid=\"9037\">liver cancer<\/span><\/li><li>UKMEC 4**: <span class=\"concept\" data-cid=\"9038\">current breast cancer<\/span><\/li><\/ul><br \/><br \/>*proven risks generally outweigh the advantages<br \/>**a condition which represents an unacceptable risk if the contraceptive method is used","notes_hash":"06f1b90f646e8f41b9de05ed4aa1689c","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>Faculty of Sexual and Reproductive Healthcare<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_337\" data-linkid=\"337\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_337\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16<\/span><button type=\"button\" style=\"\" id=\"link_dislike_337\" data-linkid=\"337\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_337\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/cec-ceu-guidance-implants-feb-2014\/\">Progestogen-only Implants<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"281":{"concept_text":"Implantable contraceptives (Nexplanon) - subdermal","concept_percentile":"48"},"282":{"concept_text":"Nexplanon - main mechanism of action is inhibition of ovulation","concept_percentile":"83"},"283":{"concept_text":"Contraceptives - time until effective (if not first day period):\n   - instant: IUD\n   - 2 days: POP\n   - 7 days: COC, injection, implant, IUS","concept_percentile":"80"}},"category_name":"Reproductive","subcategory_name":"Contraception","comment_count":6},"",[]]